• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Biodexa Licenses P 1 Drug Candidate from Otsuka for Rare Cancer

    PHARMIWEB

    Biodexa Enrolls First EU Patients in Pivotal Serenta FAP Trial

    GLOBENEWSWIRE

    Biodexa Files CTA for Phase 3 Serenta Trial in FAP in Europe

    GLOBENEWSWIRE

    Biodexa activates first site for Phase 3 Serenta trial in FAP

    GLOBENEWSWIRE

    Biodexa`s eRapa in FAP Gets Orphan Drug Status in Europe

    GLOBENEWSWIRE

    Biodexa’s FAP Drug Gets FDA Fast Track After Positive Ph 2 Results

    ACCESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.